secwatch.observer — SEC 8-K summary
======================================

Issuer:     Perspective Therapeutics, Inc. (CATX)
CIK:        0000728387
Form:       8-K
Filed at:   2024-03-06T23:59:59+00:00
Accession:  0001437749-24-006845
Event type: other_material
Sentiment:  neutral
Materiality: 0.75
Item codes: 1.01, 3.02, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Perspective Therapeutics raises $87.4M in private placement and acquires cGMP manufacturing facility
--------------------------------------------------------------------------------

- Gross proceeds of $87.4M from sale of 92,009,981 shares at $0.95/share; Lantheus to purchase $57.4M.
- Acquired 11,500 sq ft cGMP-compliant facility in Somerset, NJ from Lantheus for Pb-labeled radiopharmaceuticals.
- Net proceeds to fund R&D, clinical trials, manufacturing, and general corporate purposes.
- Registration rights agreement filed to register resale of shares with SEC.
- Facility acquisition is part of a strategic collaboration with Lantheus announced Jan 9, 2024.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/728387/000143774924006845/0001437749-24-006845-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/728387/000143774924006845/isr20240305_8k.htm
  HTML page:      https://secwatch.observer/filing/0001437749-24-006845

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer